YOUR SEARCH FOR Text 43 RESULTS
21 of Total
Incyte Reports 2024 Third Quarter Financial Results and Provides Updates on Key Clinical Programs |
… View all news Incyte Reports 2024 Third Quarter Financial Results … secondary endpoints in patients with squamous cell anal carcinoma (SCAC) receiving …
22 of Total
Incyte Reports Third Quarter 2025 Financial Results and Provides Business Updates | Incyte
… View all news Incyte Reports Third Quarter 2025 Financial Results … ® ) as first-line treatment for diffuse large B-cell lymphoma (DLBCL) is ongoing, with data …
23 of Total
Incyte Reports Fourth Quarter and Full Year 2025 Financial Results | Incyte
… View all news Incyte Reports Fourth Quarter and Full Year 2025 … and Zynyz ® (retifanlimab-dlwr) in squamous cell carcinoma of the anal canal (SCAC). Cost of …
24 of Total
Incyte Reports 2025 First Quarter Financial Results and Provides Updates on Key Clinical Programs |
… View all news Incyte Reports 2025 First Quarter Financial Results … (CD19) Relapsed or refractory diffuse large B-cell lymphoma (DLBCL): Phase 3 (B-MIND) …
25 of Total
Incyte Stories from Researchers and Scientists | Incyte.com
… Incyte in 2026 and Beyond: Focus, Momentum & Patient … Federowicz Advancing our Mission to Solve On. B-cell Lymphoma (DLBCL) By the Numbers Incyte Gets …
26 of Total
What Can JAK Inhibition Do? More Than You Might Think | Incyte.com
… November 20, 2022 What Can JAK Inhibition Do? More Than You Might … a chain of interactions between proteins in a cell with three key parts: Janus kinases (JAKs), …
27 of Total
Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advance
… View all news Incyte Announces Positive CHMP Opinion for Zynyz® … for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC) January …
28 of Total
Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatm
… View all news Incyte Announces the European Commission Approval of … the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC) March 6, …
29 of Total
Serving Patients Through Innovation | Incyte Stories
… May 24, 2023 Serving Patients Through Innovation At Incyte, our passion … used to treat certain types of diffuse large B-cell lymphoma (DLBCL) and being evaluated for …
30 of Total
Press Releases | Incyte
… The information contained in press releases … the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC) February …